Uncertainty looms for Indian drugmakers exporting to the US amid potential tariffs and trade discussions, impacting ...

WuxiAppTec raised HK$7.70 billion (US$981 million) in a sale of additional shares to fund its global expansion.

Major players such as Sun Pharma, Dr. Reddy’s Laboratories, Cipla, Divi’s Laboratories, Aurobindo Pharma, Lupin, and Biocon faced market volatility.

A federal judge has blocked a new Arkansas law that would have prohibited pharmacy benefit managers, or PBMs—middlemen companies who set drug prices—from owning ...